Chika Kato
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation.
Journal: Leukemia research
Published: August 30, 2025
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 29, 2025
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study.
Journal: Transplantation and cellular therapy
Published: July 08, 2025
Real-World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 10, 2025
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center.
Journal: Bone marrow transplantation
Published: March 10, 2025
Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 05, 2025
Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 26, 2025
Drug-induced liver injury due to granulocyte colony-stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation.
Journal: Vox sanguinis
Published: January 02, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults.
Journal: Leukemia research
Published: November 20, 2024
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience.
Journal: Frontiers in immunology
Published: November 03, 2024
Last Updated: 09/26/2026